One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Complete Revascularization vs Culprit Lesion–Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial InfarctionResults From the COMPLETE Randomized Clinical Trial
Shamir R. Mehta, MD, MSc; Jia Wang, MSc; David A. Wood, MD; et al.
doi : 10.1001/jamacardio.2022.3032
November 2022, Vol 7, No. 11, Pages 1088-1177
Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial
Ki Hong Choi, MD; Yong Hwan Park, MD; Young Bin Song, MD, PhD; et al.
Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac ProceduresThe UNIVERSAL Randomized Clinical Trial
Sanjit S. Jolly, MD, MSc; Sulaiman AlRashidi, MD; Marc-André d’Entremont, MD, MPH; Omar Alansari, MD;Bradley Brochu, MD; Laura Heenan, MSc; Elizabeth Skuriat, MSc; Jessica Tyrwhitt, BSc; Michael Raco, MD;Michael Tsang, MD, MSc; Nicholas Valettas, MD, MASc; James L. Velianou, MD; Tej Sheth, MD;Matthew Sibbald, MD, PhD; Shamir R. Mehta, MD, MSc; Natalia Pinilla-Echeverri, MD, MSc;Jon David Schwalm, MD, MSc; Madhu K. Natarajan, MD, MSc; Andrew Kelly, MD; Elie Akl, MD;Sarah Tawadros, MBBCh; Mercedes Camargo, MD, MASc; Walaa Faidi, MSc; John Bauer, BMRSc;Rachel Moxham, BSc; James Nkurunziza, MD; Gustavo Dutra, MD; Jose Winter, MD
Association of Donors With US Public Health Service Risk Criteria and Outcomes After Adult vs Pediatric Cardiac Transplant
Danielle S. Burstein, MD; Joseph W. Rossano, MD, MS; JoAnn Lindenfeld, MD; et al.
Measured Blood Pressure, Genetically Predicted Blood Pressure, and Cardiovascular Disease Risk in the UK Biobank
So Mi Jemma Cho, PhD; Satoshi Koyama, MD, PhD; Yunfeng Ruan, PhD; et al.
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure ControlA Secondary Analysis of a Randomized Clinical Trial
Byron C. Jaeger, PhD; Adam P. Bress, PharmD, MS; Joshua D. Bundy, PhD; et al.
Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart FailureA Secondary Analysis of EMPEROR-Pooled
João Pedro Ferreira, MD, PhD; Faiez Zannad, MD, PhD; Javed Butler, MD, MPH; et al.
Association of Thoracic Aortic Aneurysm Size With Long-term Patient OutcomesThe KP-TAA Study
Matthew D. Solomon, MD, PhD; Thomas Leong, MPH; Sue Hee Sung, MPH; et al.
Distribution of High-Sensitivity Cardiac Troponin and N-Terminal Pro–Brain Natriuretic Peptide in Healthy Transgender People
Dina N. Greene, PhD; Robert L. Schmidt, MD, PhD; Robert H. Christenson, PhD; et al.
Navigating Cardiology’s Leaky Pipeline
Courtney Julia Burns, BSE
Fluoroscopic Guidance for Femoral Artery Access—Pushing Patients Out of the Plane Without a Parachute?
Alexander C. Fanaroff, MD, MHS; Jay Giri, MD, MPH
Finding the Words and Data to Discuss Donor Characteristics With Heart Transplant Recipients and FamiliesReconsidering Risk
Amanda R. Vest, MBBS, MPH; Elizabeth D. Blume, MD
Blood Pressure Control After SPRINT—Back to Reality
Daniel W. Jones, MD; Donald Clark III, MD; Michael E. Hall, MD
A Man in His 50s With Cardiac Tamponade From Ruptured Coronary Artery Aneurysm
Hongwei Zhang, MD; Hao Niu, MD; Zhenghua Xiao, MD
Benefit of Implantable Cardioverter-Defibrillators in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
Alexander H. Maass, MD, PhD; Moniek G. P. J. Cox, MD, PhD
Benefit of Implantable Cardioverter-Defibrillators in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia—Reply
Silvia G. Priori, MD, PhD; Andrea Mazzanti, MD, PhD
Is CABG Indicated in Patients With Ischemic Cardiomyopathy?
Eric R. Bates, MD
Is CABG Indicated in Patients With Ischemic Cardiomyopathy?—Reply
Yousif Ahmad, BMBS, PhD; Alexandra J. Lansky, MD; Eric J. Velazquez, MD
The Smart(est) Choice for Dual Antiplatelet Therapy Is a Patient-Directed One
Ajay J. Kirtane, MD, SM; Roxana Mehran, MD
